Literature DB >> 28752408

The NLRP3 Inflammasome: An Important Driver of Neuroinflammation in Hemorrhagic Stroke.

Shao-Jun Yang1, Gao-Feng Shao1, Jiang-Li Chen1, Jie Gong2.   

Abstract

Hemorrhagic stroke is a devastating clinical event with no effective medical treatment. Neuroinflammation, which follows a hemorrhagic stroke, is an important element that involves both acute brain injury and subsequent brain rehabilitation. Therefore, delineating the key inflammatory mediators and deciphering their pathophysiological roles in hemorrhagic strokes is of great importance in the development of novel therapeutic targets for this disease. The NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome is a multi-protein complex that is localized within the cytoplasm. This NOD-like receptor orchestrates innate immune responses to pathogenic organisms and cell stress through the activation of caspase-1 and the maturation of the proinflammatory cytokines such as interleukin-1β (IL-1β) and IL-18. Mounting evidence has demonstrated that when the NLRP3 inflammasome is activated, it exerts harmful effects on brain tissue after a hemorrhagic stroke. This review article summarizes the current knowledge regarding the role and the underlying mechanisms of the NLRP3 inflammasome in the pathophysiological processes of hemorrhagic strokes. A better understanding of the function and regulation of the NLRP3 inflammasome in hemorrhagic strokes will provide clues for devising novel therapeutic strategies to fight this disease.

Entities:  

Keywords:  Brain injury; Hemorrhagic stroke; Inflammasome; NLRP3; Neuroinflammation

Mesh:

Substances:

Year:  2017        PMID: 28752408     DOI: 10.1007/s10571-017-0526-9

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  66 in total

1.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

2.  Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury.

Authors:  Yan-Chun Wang; Peng-Fei Wang; Huang Fang; Jing Chen; Xiao-Yi Xiong; Qing-Wu Yang
Journal:  Stroke       Date:  2013-07-09       Impact factor: 7.914

3.  Microglia regulate blood clearance in subarachnoid hemorrhage by heme oxygenase-1.

Authors:  Nils Schallner; Rambhau Pandit; Robert LeBlanc; Ajith J Thomas; Christopher S Ogilvy; Brian S Zuckerbraun; David Gallo; Leo E Otterbein; Khalid A Hanafy
Journal:  J Clin Invest       Date:  2015-05-26       Impact factor: 14.808

Review 4.  Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation.

Authors:  Yu Zhou; Yanchun Wang; Jian Wang; R Anne Stetler; Qing-Wu Yang
Journal:  Prog Neurobiol       Date:  2013-11-26       Impact factor: 11.685

5.  Hematoma resolution as a target for intracerebral hemorrhage treatment: role for peroxisome proliferator-activated receptor gamma in microglia/macrophages.

Authors:  Xiurong Zhao; Guanghua Sun; Jie Zhang; Roger Strong; Weitao Song; Nicole Gonzales; James C Grotta; Jaroslaw Aronowski
Journal:  Ann Neurol       Date:  2007-04       Impact factor: 10.422

Review 6.  Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options.

Authors:  Timothy J Kleinig; Robert Vink
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

Review 7.  Inflammasomes: guardians of cytosolic sanctity.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Immunol Rev       Date:  2009-01       Impact factor: 12.988

8.  Melatonin attenuated early brain injury induced by subarachnoid hemorrhage via regulating NLRP3 inflammasome and apoptosis signaling.

Authors:  Yushu Dong; Chongxi Fan; Wei Hu; Shuai Jiang; Zhiqiang Ma; Xiaolong Yan; Chao Deng; Shouyin Di; Zhenlong Xin; Guiling Wu; Yang Yang; Russel J Reiter; Guobiao Liang
Journal:  J Pineal Res       Date:  2016-02-15       Impact factor: 13.007

9.  NLRP3 is Required for Complement-Mediated Caspase-1 and IL-1beta Activation in ICH.

Authors:  Sheng-Tao Yao; Fang Cao; Jia-Lin Chen; Wei Chen; Rui-Ming Fan; Gang Li; You-Chao Zeng; Song Jiao; Xiang-Ping Xia; Chong Han; Qi-Shan Ran
Journal:  J Mol Neurosci       Date:  2016-12-08       Impact factor: 3.444

10.  NLRP3 inflammasome contributes to inflammation after intracerebral hemorrhage.

Authors:  Qingyi Ma; Sheng Chen; Qin Hu; Hua Feng; John H Zhang; Jiping Tang
Journal:  Ann Neurol       Date:  2014-01-02       Impact factor: 10.422

View more
  16 in total

1.  Rosmarinic Acid Mitigates Lipopolysaccharide-Induced Neuroinflammatory Responses through the Inhibition of TLR4 and CD14 Expression and NF-κB and NLRP3 Inflammasome Activation.

Authors:  Yicong Wei; Jianxiong Chen; Yonghong Hu; Wei Lu; Xiaoqin Zhang; Ruiguo Wang; Kedan Chu
Journal:  Inflammation       Date:  2018-03       Impact factor: 4.092

2.  NLRP3 inflammasome-mediated choroid plexus hypersecretion contributes to hydrocephalus after intraventricular hemorrhage via phosphorylated NKCC1 channels.

Authors:  Zhaoqi Zhang; Qiang Tan; Peiwen Guo; Suna Huang; Zhengcai Jia; Xin Liu; Hua Feng; Yujie Chen
Journal:  J Neuroinflammation       Date:  2022-06-21       Impact factor: 9.587

3.  Clonal Hematopoiesis Is Associated With Higher Risk of Stroke.

Authors:  Romit Bhattacharya; Seyedeh M Zekavat; Jeffrey Haessler; Myriam Fornage; Laura Raffield; Md Mesbah Uddin; Alexander G Bick; Abhishek Niroula; Bing Yu; Christopher Gibson; Gabriel Griffin; Alanna C Morrison; Bruce M Psaty; William T Longstreth; Joshua C Bis; Stephen S Rich; Jerome I Rotter; Russell P Tracy; Adolfo Correa; Sudha Seshadri; Andrew Johnson; Jason M Collins; Kathleen M Hayden; Tracy E Madsen; Christie M Ballantyne; Siddhartha Jaiswal; Benjamin L Ebert; Charles Kooperberg; JoAnn E Manson; Eric A Whitsel; Pradeep Natarajan; Alexander P Reiner
Journal:  Stroke       Date:  2021-11-08       Impact factor: 10.170

4.  Microglial Inflammasome Activation in Penetrating Ballistic-Like Brain Injury.

Authors:  Stephanie W Lee; Shyam Gajavelli; Markus S Spurlock; Cody Andreoni; Juan Pablo de Rivero Vaccari; M Ross Bullock; Robert W Keane; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2018-04-02       Impact factor: 5.269

Review 5.  Pyroptosis in stroke-new insights into disease mechanisms and therapeutic strategies.

Authors:  Xue Gou; Dan Xu; Fengyang Li; Kai Hou; Weirong Fang; Yunman Li
Journal:  J Physiol Biochem       Date:  2021-05-04       Impact factor: 4.158

Review 6.  NLR-Dependent Regulation of Inflammation in Multiple Sclerosis.

Authors:  Marjan Gharagozloo; Katsiaryna V Gris; Tara Mahvelati; Abdelaziz Amrani; John R Lukens; Denis Gris
Journal:  Front Immunol       Date:  2018-01-18       Impact factor: 7.561

7.  Inhibited CSF1R Alleviates Ischemia Injury via Inhibition of Microglia M1 Polarization and NLRP3 Pathway.

Authors:  Xiaoxue Du; Yuzhen Xu; Shijia Chen; Marong Fang
Journal:  Neural Plast       Date:  2020-08-28       Impact factor: 3.599

Review 8.  Microglia and CNS Interleukin-1: Beyond Immunological Concepts.

Authors:  Xiaoyu Liu; Ning Quan
Journal:  Front Neurol       Date:  2018-01-23       Impact factor: 4.003

9.  Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms.

Authors:  Dong Wang; Xin Xu; Yin-Gang Wu; Li Lyu; Zi-Wei Zhou; Jian-Ning Zhang
Journal:  Neural Regen Res       Date:  2018-05       Impact factor: 5.135

10.  NLRP3 inhibition attenuates early brain injury and delayed cerebral vasospasm after subarachnoid hemorrhage.

Authors:  William S Dodd; Imaray Noda; Melanie Martinez; Koji Hosaka; Brian L Hoh
Journal:  J Neuroinflammation       Date:  2021-07-20       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.